Targeted Ablation to Isolate Scar Channels Causing Ventricular Tachycardia
Key facts
- Where
- Valhalla, United StatesSee the site
Where in United States
- Westchester Medical CenterValhalla, United StatesContact: Jason T Jacobson, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- New York Medical College
- Trial code
- NCT07814079
- Record updated
- 10 September 2026
- Original description
The goal of this study is to map conducting channels within scar that cause ventricular tachycardia (VT) in patients with scar in their hearts in order to block these channels from causing VT with targeted radiofrequency ablation (cautery).Read full original descriptionShow less
Segmental Substrate Isolation for the Treatment of Ventricular Tachycardia in Patients With Structural Heart Disease
The goal of this study is to map conducting channels within scar that cause ventricular tachycardia (VT) in patients with scar in their hearts in order to block these channels from causing VT with targeted radiofrequency ablation (cautery).
Participants undergoing VT ablation mapping of these channels by pacing many sites within the scar area and determining where these channels exit the scar into normal tissue. These exits will be ablated. Immediate success and success at 1 year will be evaluated.
Inclusion: Patients with structural heart disease undergoing VT ablation.
Exclusion: Cardiogenic shock or NYHA Class IV heart failure and not a candidate for mechanical circulatory support for the procedure (percutaneous left ventricular assist device (LVAD), extracorporeal membrane oxygenation, or implanted LVAD); Unable or unwilling to sign consent; Absence of substrate during initial voltage mapping.